Results

Total Results: 5,434 records

Showing results for "stages".

  1. hcup-us.ahrq.gov/reports/methods/MS2021-03-NHQDRMethodsReport.pdf
    December 09, 2021 - Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2021 National Healthcare Quality and Disparities Report (NHQDR) HCUP Methods Series Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2021 National Healthcar…
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-future_research.pdf
    May 01, 2012 - Future Research Needs for Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers, Long-Term Effectiveness in All Ages, and Variability in Prevalence, Diagnosis, and Treatment Future Research Needs Paper Number 9 Future Research Needs for Attention Deficit Hyperactivity Disorder:…
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/asthma-immunotherapy-2010_executive.pdf
    January 01, 2010 - 1 Comparative Effectiveness Review Number 111 Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review Executive Summary Background Allergic rhinitis is a widespread clinical problem, estimated to affect 20 to 40 percent of the popu…
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
    January 01, 2006 - Comparative Effectiveness Review 118 Appendix A. Pharmacokinetics, Indications and Dosing of Included Drugs Drug and Trade Name (Trade names provided only for drugs under patent.) Half-life or other relevant pharmacokinetic feature Labeled indications Dosing (oral doses) Dose adjustments fo…
  5. effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables1.pdf
    January 01, 2009 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest, Continuously Enrolled Medicare Parts A and B Fee-for-Service (FFS) Population, by Class of Drug and Active Ingredient, 2006-2009 Note: An asterisk (*) signifies a small cell count (less than 11). Persons per 10…
  6. effectivehealthcare.ahrq.gov/sites/default/files/data-points-6-tables.xls
    January 01, 2006 - 1 Number of Beneficiaries With at Least One Part A, B, or D Drug Claim for a Biologic of Interest (among continuously enrolled AB FFS population) by Class of Drug and Active Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11). Use filters to rank by beneficiary count. …
  7. www.ahrq.gov/sites/default/files/wysiwyg/professionals/education/continuing-ed/moc_sms.pdf
    March 29, 2016 - Patient Self-Management Support: A Chronic Conditions Practice Improvement Activity Advancing Excellence in Health Care–•–www.ahrq.gov Patient Self­Management Support A Chronic Conditions Practice Improvement Activity User Guide Resources To use a screen reader application with this module, please change your …
  8. www.ahrq.gov/sites/default/files/publications/files/crctoolkit.pdf
    December 01, 2010 - Toolkit for the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer Intervention Toolkit for the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer Intervention These materials enable implementation of the …
  9. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/crctoolkit/crctoolkit.pdf
    December 01, 2010 - Toolkit for the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer Intervention Toolkit for the System Approach to Tracking and Increasing Screening for Public Health Improvement of Colorectal Cancer Intervention These materials enable implementation of the …
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-3.pdf
    August 01, 2022 - Acute Treatments for Episodic Migraine: Surveillance Report 3 Acute Treatments for Episodic Migraine: Surveillance Report 3 Literature Update Period: December 31, 2021, through March 21, 2022 Background and Purpose This report is the third and final surveillance report for the Agency for Healthcare Research an…
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
    May 01, 2022 - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 1 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 3 Literature Update Period: November 2021 through Mid-January 2022 Overview This is th…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
    March 01, 2022 - Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 1 Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 Literature Update Period: August 2021 through October 2021 Overview This is the seco…
  13. hcup-us.ahrq.gov/reports/methods/MS2024-01-NHQDRMethodsReport.pdf
    November 25, 2024 - Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the 2024 National Healthcare Quality and Disparities Report (NHQDR) HCUP Methods Series Methods Report Describing 2016-2021 HCUP Data in the National Healthcare Quality and Disparities Report (NHQDR) Report #202…
  14. www.ahrq.gov/sites/default/files/wysiwyg/data/hfmd-methodology-report.pdf
    August 02, 2024 - AHRQ Hospital Financial Measures Database Methodology Report AHRQ HOSPITAL FINANCIAL MEASURES DATABASE Methodology Report U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Prepared by: Rhona Limcangc…